首页 > 最新文献

中华眼外伤职业眼病杂志最新文献

英文 中文
The efficacy of orthokeratology and fine training for patient with ametropic amblyopia 矫形角膜镜及精细训练治疗屈光性弱视的疗效观察
Pub Date : 2019-11-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.014
Jun Tian
Objective To evaluate the efficacy of orthokeratology combined with monocular partial occlusion and fine training for the treatment of ametropic amblyopia. Methods A prospective study.The data of 86 children with ametropic amblyopia in this hospital from Dec.2016 to May 2018 were analyzed.All cases were randomly divided into two groups, with each group of 43 cases.All cases were partially coverd with a single eye.The control group adopted fine training.The research group underwent orthokeratology combined with fine training, and both groups were treated for 6 months. Results The total effective rate of the research group(97.67%)was higher than that of the control group(81.40%)(χ2=4.468, P=0.035). The best corrected visual acuity (LogMAR) of the research group (0.1±0.01) was better than that of the control group (0.15±0.02) (t=14.663, P=0.000). Visual sensitivity of the research group was higher than that of the control group(t=4.428, P=0.000). The adjustment flexibility and adjustment range of the research group were greater than that of the control group, and the adjustment hysteresis of the research group was less than that of the control group(P=0.000). Conclusion The combination of orthokeratology, monocular partial occlusion and fine training is effective for the treatment of children with ametropic amblyopia. Key words: Orthokeratology, corneal; Training, fine; Amblyopia, ametropia; Children
目的评价角膜塑形术联合单眼部分遮挡和精细训练治疗屈光性弱视的疗效。方法前瞻性研究。对该院2016年12月至2018年5月86例屈光性弱视患儿的资料进行分析。所有病例随机分为两组,每组43例。所有病例均部分被单眼遮挡。对照组采用精细训练。研究组采用角膜塑形术结合精细训练,两组均治疗6个月。结果研究组总有效率(97.67%)高于对照组(81.40%)(χ2=4.468, P=0.035)。研究组的最佳矫正视力(LogMAR)(0.1±0.01)优于对照组(0.15±0.02)(t=14.663, P=0.000)。研究组视觉敏感度高于对照组(t=4.428, P=0.000)。研究组的调整灵活性和调整幅度均大于对照组,研究组的调整滞后小于对照组(P=0.000)。结论角膜塑形术、单眼部分遮挡和精细训练相结合是治疗儿童屈光性弱视的有效方法。关键词:角膜塑形术;角膜;培训、罚款;弱视、屈光异常;孩子们
{"title":"The efficacy of orthokeratology and fine training for patient with ametropic amblyopia","authors":"Jun Tian","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.014","url":null,"abstract":"Objective \u0000To evaluate the efficacy of orthokeratology combined with monocular partial occlusion and fine training for the treatment of ametropic amblyopia. \u0000 \u0000 \u0000Methods \u0000A prospective study.The data of 86 children with ametropic amblyopia in this hospital from Dec.2016 to May 2018 were analyzed.All cases were randomly divided into two groups, with each group of 43 cases.All cases were partially coverd with a single eye.The control group adopted fine training.The research group underwent orthokeratology combined with fine training, and both groups were treated for 6 months. \u0000 \u0000 \u0000Results \u0000The total effective rate of the research group(97.67%)was higher than that of the control group(81.40%)(χ2=4.468, P=0.035). The best corrected visual acuity (LogMAR) of the research group (0.1±0.01) was better than that of the control group (0.15±0.02) (t=14.663, P=0.000). Visual sensitivity of the research group was higher than that of the control group(t=4.428, P=0.000). The adjustment flexibility and adjustment range of the research group were greater than that of the control group, and the adjustment hysteresis of the research group was less than that of the control group(P=0.000). \u0000 \u0000 \u0000Conclusion \u0000The combination of orthokeratology, monocular partial occlusion and fine training is effective for the treatment of children with ametropic amblyopia. \u0000 \u0000 \u0000Key words: \u0000Orthokeratology, corneal; Training, fine; Amblyopia, ametropia; Children","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"92 1","pages":"866-871"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88574202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Observation on the efficacy of single intravitreal injection of conbercept for the treatment of diabetic macular edema 单次玻璃体内注射康伯利治疗糖尿病性黄斑水肿的疗效观察
Pub Date : 2019-11-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.013
Xiaopu Yang, Wenzhan Wang, Hao Yao, Dong Zhang
Objective To observe the short-term efficacy of single intravitreal injection of conbercept in the treatment of diabetic macular edema (DME). Methods The clinical data of 42 eyes of 37 cases with DME from Oct.2015 to Dec.2017 in Jiaxian County Maternal and Child Health Hospital were analyzed retrospectively.All cases were treated with single intravitreal injection of conbercept. The visual acuity, central macular thickness (CMT) and fluorescein fundus angiography (FFA)before and after injection were analyzed. Results Visual acuity was significantly ameliorated at 1 day, 1 and 4 weeks after surgery (P<0.05), and CMT was dramatically reduced (P<0.01). FFA data showed no leakage in 11 eyes, less leakage in 28 eyes and no obvious change in 3 eyes at 4 weeks after treatment. The general effective rate was 92.86%. Conclusion Intravitreal injection of conbercept improves vision and reduces macular edema in a short period. Key words: Edema, macular, diabetic; Conbercept, injection, intravitreal, single time; Efficacy
目的观察单次玻璃体腔内注射康宁治疗糖尿病性黄斑水肿(DME)的近期疗效。方法回顾性分析嘉县妇幼保健院2015年10月至2017年12月收治的37例42眼DME的临床资料。所有病例均采用单次玻璃体腔内注射。分析注射前后的视力、中央黄斑厚度(CMT)和荧光素眼底血管造影(FFA)。结果术后1天、1周、4周视力明显改善(P<0.05), CMT明显降低(P<0.01)。治疗后4周FFA数据显示11眼无渗漏,28眼渗漏较少,3眼无明显变化。总有效率为92.86%。结论玻璃体内注射可在短时间内改善视力,减轻黄斑水肿。关键词:水肿,黄斑,糖尿病;概念,注射,玻璃体内注射,单次;功效
{"title":"Observation on the efficacy of single intravitreal injection of conbercept for the treatment of diabetic macular edema","authors":"Xiaopu Yang, Wenzhan Wang, Hao Yao, Dong Zhang","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.013","url":null,"abstract":"Objective \u0000To observe the short-term efficacy of single intravitreal injection of conbercept in the treatment of diabetic macular edema (DME). \u0000 \u0000 \u0000Methods \u0000The clinical data of 42 eyes of 37 cases with DME from Oct.2015 to Dec.2017 in Jiaxian County Maternal and Child Health Hospital were analyzed retrospectively.All cases were treated with single intravitreal injection of conbercept. The visual acuity, central macular thickness (CMT) and fluorescein fundus angiography (FFA)before and after injection were analyzed. \u0000 \u0000 \u0000Results \u0000Visual acuity was significantly ameliorated at 1 day, 1 and 4 weeks after surgery (P<0.05), and CMT was dramatically reduced (P<0.01). FFA data showed no leakage in 11 eyes, less leakage in 28 eyes and no obvious change in 3 eyes at 4 weeks after treatment. The general effective rate was 92.86%. \u0000 \u0000 \u0000Conclusion \u0000Intravitreal injection of conbercept improves vision and reduces macular edema in a short period. \u0000 \u0000 \u0000Key words: \u0000Edema, macular, diabetic; Conbercept, injection, intravitreal, single time; Efficacy","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"37 1","pages":"862-865"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81040652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of intraocular lens diopter calculation for high myopia with cataract 高度近视合并白内障人工晶状体屈光度计算的准确性
Pub Date : 2019-11-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.006
Jun-zheng Dong
Objective To compare the calculation accuracy with three different intraocular lens (IOL) diopter formulas for high myopia with cataract. Methods The data of 172 eyes of 172 patients with high myopia with cataract from Feb. 2017 to Nov. 2018 in this hospital were analyzed retrospectively. All cases were divided into 3 groups according to axial length (AL). AL of group A was 26.1-28.0 mm, 28.1-30.0 mm in group B and ≥30.1 mm in group C. The intraocular lens diopter of three groups were calculated with SRK/T, Haigis and Barrett Universal II formulas, respectively. The accuracy of IOL diopter among three formulas were compared in each groups at 1 month postopeeratively. Results The difference of IOL diopter accuracy in group A were not statistically significant among three formulas (P=1.000). The IOL diopter with Barrett Universal II was the most accurate in group B and group C. Barrett Universal II was the highest (70.9%) in eyes with error ≤±0.5 D between actual diopter and expected diopter. The difference was statistically significant among three formulas (χ2=18.801, P=0.000). The difference in percentage of prediction error within ±1.0 D was not statistically significant among the three formulas (χ2=5.007, P=0.082). Conclusion The calculation accuracy of IOL diopter with Barrett Universal II formula is the highest for high myopia with cataract. Key words: Cataract, high myopia; Lens, intraocular; Accuracy, calculation, diopter
目的比较三种不同人工晶状体屈光度公式对高度近视合并白内障的计算精度。方法回顾性分析该院2017年2月至2018年11月收治的172例高度近视合并白内障患者172只眼的资料。所有病例根据轴向长度(AL)分为3组。A组AL为26.1 ~ 28.0 mm, B组为28.1 ~ 30.0 mm, c组≥30.1 mm。三组分别采用SRK/T、Haigis、Barrett通用II公式计算人工晶状体屈光度。比较各组术后1个月人工晶状体屈光度的准确性。结果A组3种配方间人工晶状体屈光度精度差异无统计学意义(P=1.000)。Barrett Universal II型人工晶状体屈光度在B组和c组最准确,Barrett Universal II型人工晶状体屈光度与预期屈光度误差≤±0.5 D时最高(70.9%)。3种配方间差异有统计学意义(χ2=18.801, P=0.000)。3种公式预测误差在±1.0 D范围内的百分比差异无统计学意义(χ2=5.007, P=0.082)。结论巴雷特通用型人工晶状体屈光度公式对高度近视合并白内障患者的计算精度最高。关键词:白内障;高度近视;镜头,眼内;精度,计算,屈光度
{"title":"Accuracy of intraocular lens diopter calculation for high myopia with cataract","authors":"Jun-zheng Dong","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.006","url":null,"abstract":"Objective \u0000To compare the calculation accuracy with three different intraocular lens (IOL) diopter formulas for high myopia with cataract. \u0000 \u0000 \u0000Methods \u0000The data of 172 eyes of 172 patients with high myopia with cataract from Feb. 2017 to Nov. 2018 in this hospital were analyzed retrospectively. All cases were divided into 3 groups according to axial length (AL). AL of group A was 26.1-28.0 mm, 28.1-30.0 mm in group B and ≥30.1 mm in group C. The intraocular lens diopter of three groups were calculated with SRK/T, Haigis and Barrett Universal II formulas, respectively. The accuracy of IOL diopter among three formulas were compared in each groups at 1 month postopeeratively. \u0000 \u0000 \u0000Results \u0000The difference of IOL diopter accuracy in group A were not statistically significant among three formulas (P=1.000). The IOL diopter with Barrett Universal II was the most accurate in group B and group C. Barrett Universal II was the highest (70.9%) in eyes with error ≤±0.5 D between actual diopter and expected diopter. The difference was statistically significant among three formulas (χ2=18.801, P=0.000). The difference in percentage of prediction error within ±1.0 D was not statistically significant among the three formulas (χ2=5.007, P=0.082). \u0000 \u0000 \u0000Conclusion \u0000The calculation accuracy of IOL diopter with Barrett Universal II formula is the highest for high myopia with cataract. \u0000 \u0000 \u0000Key words: \u0000Cataract, high myopia; Lens, intraocular; Accuracy, calculation, diopter","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"27 1","pages":"826-832"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84376018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of optical coherence tomographic angiography in the treatment and follow-up of macular degeneration 光学相干断层血管造影在黄斑变性治疗及随访中的作用
Pub Date : 2019-11-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.012
Shao Ling, Y. Shu, Chen Ceying, Du Min, Li Yan, Z. Song
Objective To evaluate the role of optical coherence tomographic angiography(OCTA) in anti-vascular endothelial growth factor(VEGF) treating the neovascular age-related macular degeneration(nAMD) and follow-up. Methods Total of 41 eyes of 33 patients with nAMD in the Second People’s Hospital of Zhengzhou from May 2018 to Oct. 2018 were analyzed retrospectively. All cases were treated with intravitreal injection of ranibizumab(IVR). All cases were followed up for 6 months. Results At 6 months after treatment, the OCT and OCTA showed the average central retinat thickness reduced (t=31.454, P=0.000), and CNV flow areas shrinked after IVR(t=4.117, P=0.000). The decrease of CNV flow areas in eyes with dense-network CNV was more obvious than that in loose-network CNV (Z=3.686, P=0.000). Conclusion OCTA is a reliable method to observe dynamically the strutures and quantified the blood flow area of CNV. It is significant in treatment and follow-up evaluation of nAMD. Key words: Degeneration, macular, age-related, neovascular; Angiography, OCT; Therapy, anti-VEGF
目的探讨光学相干层析血管造影(OCTA)在抗血管内皮生长因子(VEGF)治疗新生血管性年龄相关性黄斑变性(nAMD)中的作用及随访。方法回顾性分析郑州市第二人民医院2018年5月至2018年10月收治的33例nAMD患者的41眼。所有病例均采用玻璃体内注射雷尼单抗(IVR)治疗。所有病例均随访6个月。结果治疗后6个月,OCT和OCTA显示视网膜中央平均厚度减小(t=31.454, P=0.000), IVR后CNV血流面积缩小(t=4.117, P=0.000)。密集网状CNV组眼底CNV流面积减小较松散网状CNV组更为明显(Z=3.686, P=0.000)。结论OCTA是一种可靠的动态观察CNV结构和定量血流面积的方法。对nAMD的治疗及随访评价具有重要意义。关键词:退行性变,黄斑,年龄相关性,新生血管;血管造影术,10月;治疗,抗
{"title":"The role of optical coherence tomographic angiography in the treatment and follow-up of macular degeneration","authors":"Shao Ling, Y. Shu, Chen Ceying, Du Min, Li Yan, Z. Song","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.012","url":null,"abstract":"Objective \u0000To evaluate the role of optical coherence tomographic angiography(OCTA) in anti-vascular endothelial growth factor(VEGF) treating the neovascular age-related macular degeneration(nAMD) and follow-up. \u0000 \u0000 \u0000Methods \u0000Total of 41 eyes of 33 patients with nAMD in the Second People’s Hospital of Zhengzhou from May 2018 to Oct. 2018 were analyzed retrospectively. All cases were treated with intravitreal injection of ranibizumab(IVR). All cases were followed up for 6 months. \u0000 \u0000 \u0000Results \u0000At 6 months after treatment, the OCT and OCTA showed the average central retinat thickness reduced (t=31.454, P=0.000), and CNV flow areas shrinked after IVR(t=4.117, P=0.000). The decrease of CNV flow areas in eyes with dense-network CNV was more obvious than that in loose-network CNV (Z=3.686, P=0.000). \u0000 \u0000 \u0000Conclusion \u0000OCTA is a reliable method to observe dynamically the strutures and quantified the blood flow area of CNV. It is significant in treatment and follow-up evaluation of nAMD. \u0000 \u0000 \u0000Key words: \u0000Degeneration, macular, age-related, neovascular; Angiography, OCT; Therapy, anti-VEGF","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"20 1","pages":"857-861"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79689941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research on application of dexamethasone intravitreal implant in ocular fundus diseases related to macular edema 地塞米松玻璃体内植入在黄斑水肿相关眼底疾病中的应用研究
Pub Date : 2019-11-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.016
Luyan Zhang, Gang-feng Cui
The intravitreal dexamethasone (DEX) implant is a drug sustained-release system formulated in a biodegradable copolymer, which contains the ingredient of dexamethasone.At present, the intravitreal dexamethasone implant (Ozurdex) is approved in Europe and USA for the treatment of macular edema related to central retinal vein occlusion, branch retinal vein occlusion, diabetic retinopathy and non-infectious uveitis.In addition, the treatment of macular edema secondary to other ocular fundus diseases related with inflammation such as wet age-related macular degeneration, vasoproliferative retinal tumors, Coats disease, radiation maculopathy, retinitis pigmentosa, and pars plana vitrectomy has been reported.This paper is aimed to provide a review of the research and application of DEX intravitreal implant in the treatment of macular edema in recent years, and provide a new option for the treatment of these clinical refractory diseases. Key words: Edema, macular; Dexamethasone; Implant, intravitreal
玻璃体内地塞米松(DEX)植入物是一种由含有地塞米松成分的可生物降解共聚物制成的药物缓释系统。目前,玻璃体内地塞米松植入物(Ozurdex)在欧洲和美国被批准用于治疗视网膜中央静脉阻塞、视网膜分支静脉阻塞、糖尿病视网膜病变和非感染性葡萄膜炎相关的黄斑水肿。此外,对其他与炎症相关的眼底疾病继发的黄斑水肿的治疗也有报道,如湿性年龄相关性黄斑变性、血管增殖性视网膜肿瘤、Coats病、放射性黄斑病变、视网膜色素变性和玻璃体切割。本文旨在对近年来DEX玻璃体内植入治疗黄斑水肿的研究及应用进行综述,为临床难治性疾病的治疗提供新的选择。关键词:水肿;黄斑;地塞米松;植入,intravitreal
{"title":"Research on application of dexamethasone intravitreal implant in ocular fundus diseases related to macular edema","authors":"Luyan Zhang, Gang-feng Cui","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.016","url":null,"abstract":"The intravitreal dexamethasone (DEX) implant is a drug sustained-release system formulated in a biodegradable copolymer, which contains the ingredient of dexamethasone.At present, the intravitreal dexamethasone implant (Ozurdex) is approved in Europe and USA for the treatment of macular edema related to central retinal vein occlusion, branch retinal vein occlusion, diabetic retinopathy and non-infectious uveitis.In addition, the treatment of macular edema secondary to other ocular fundus diseases related with inflammation such as wet age-related macular degeneration, vasoproliferative retinal tumors, Coats disease, radiation maculopathy, retinitis pigmentosa, and pars plana vitrectomy has been reported.This paper is aimed to provide a review of the research and application of DEX intravitreal implant in the treatment of macular edema in recent years, and provide a new option for the treatment of these clinical refractory diseases. \u0000 \u0000 \u0000Key words: \u0000Edema, macular; Dexamethasone; Implant, intravitreal","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"10 1","pages":"876-880"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78976084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis on the cause of retinal detachment after vitrectomy for open ocular trauma 开放性眼外伤玻璃体切除术后视网膜脱离原因分析
Pub Date : 2019-11-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.11.009
Hong Gu
Objective To analyze the causes of retinal detachment in patients with open ocular trauma after vitrectomy. Methods The clinical data of 129 patients with open ocular trauma underwent vitrectomy from Jul. 2013 to Jul. 2018 were retrospectively analyzed. A total of 114 patients in the non-retinal detachment group and 15 patients in the retinal detachment group were included. The cause of retinal detachment after vitrectomy for open ocular trauma were analyzed. Results There was no significant difference in gender, age or type of injury between the two groups (P>0.05). The factors of postoperative retinal detachment were related to combined with proliferative vitreoretinopathy (PVR), retinal detachment, operation time and intraoperative combined therapy. In the retinal detachment group the incidence of posperative retinal detachment in patients of PVR was higher than that in the non-retinal detachment group (P=0.002). The difference of preoperative incidence of retinal detachment (P=0.032) and later operation time (P<0.001) were statistically significant. The proportion of intraoperative scleral cryotherapy and retinotomy in the retinal detachment group (P=0.020, 0.000) was higher than that in the non-retinal detachment group during the operation. Conclusion PVR, preoperative retinal detachment, delayed surgery and over-operation during surgery are the main factors of retinal detachment after open ocular trauma surgery. Key words: Trauma, open ocular; Vitrectomy; Detachment, retinal; Vitreoretinopathy, proliferative
目的分析玻璃体切除术后开放性眼外伤患者视网膜脱离的原因。方法回顾性分析2013年7月至2018年7月收治的129例开放性眼外伤玻璃体切除术患者的临床资料。非视网膜脱离组114例,视网膜脱离组15例。分析了开放性眼外伤玻璃体切除术后视网膜脱离的原因。结果两组患者性别、年龄、损伤类型差异无统计学意义(P < 0.05)。术后发生视网膜脱离的因素与合并增殖性玻璃体视网膜病变(PVR)、视网膜脱离、手术时间及术中联合治疗有关。视网膜脱离组PVR患者术后视网膜脱离的发生率高于非视网膜脱离组(P=0.002)。术前视网膜脱离发生率(P=0.032)与术后时间差异有统计学意义(P<0.001)。术中视网膜脱离组术中巩膜冷冻及视网膜切开术的比例(P=0.020, 0.000)高于非视网膜脱离组。结论PVR、术前视网膜脱离、手术延迟及术中过度操作是开放性眼外伤术后视网膜脱离的主要因素。关键词:外伤;睁眼;玻璃体切除术;视网膜脱离;玻璃体,增生性
{"title":"Analysis on the cause of retinal detachment after vitrectomy for open ocular trauma","authors":"Hong Gu","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.11.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.11.009","url":null,"abstract":"Objective \u0000To analyze the causes of retinal detachment in patients with open ocular trauma after vitrectomy. \u0000 \u0000 \u0000Methods \u0000The clinical data of 129 patients with open ocular trauma underwent vitrectomy from Jul. 2013 to Jul. 2018 were retrospectively analyzed. A total of 114 patients in the non-retinal detachment group and 15 patients in the retinal detachment group were included. The cause of retinal detachment after vitrectomy for open ocular trauma were analyzed. \u0000 \u0000 \u0000Results \u0000There was no significant difference in gender, age or type of injury between the two groups (P>0.05). The factors of postoperative retinal detachment were related to combined with proliferative vitreoretinopathy (PVR), retinal detachment, operation time and intraoperative combined therapy. In the retinal detachment group the incidence of posperative retinal detachment in patients of PVR was higher than that in the non-retinal detachment group (P=0.002). The difference of preoperative incidence of retinal detachment (P=0.032) and later operation time (P<0.001) were statistically significant. The proportion of intraoperative scleral cryotherapy and retinotomy in the retinal detachment group (P=0.020, 0.000) was higher than that in the non-retinal detachment group during the operation. \u0000 \u0000 \u0000Conclusion \u0000PVR, preoperative retinal detachment, delayed surgery and over-operation during surgery are the main factors of retinal detachment after open ocular trauma surgery. \u0000 \u0000 \u0000Key words: \u0000Trauma, open ocular; Vitrectomy; Detachment, retinal; Vitreoretinopathy, proliferative","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"142 1","pages":"842-846"},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77344446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of efficacy between 27G and 25G vitrectomy for proliferative diabetic retinopathy 27G与25G玻璃体切除术治疗增殖性糖尿病视网膜病变的疗效比较
Pub Date : 2019-10-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.10.005
Yan Gao, Li-li Yuan, Dong-chang Zhang, Dongping Li
Objective To compare the efficacy between 27G and 25G vitrectomy for the treatment of proliferative diabetic retinopathy (PDR). Methods The data of 185 eyes of 185 cases of PDR who received vitrectomy in this hospital from Jan. 2017 to Dec. 2017 were analyzed retrospectively. All cases were divided into two groups. There were 64 eyes in the 27G vitrectomy group and 121 eyes in the 25G vitrectomy group. Results There was no significant difference in the preoperative baseline data between the two groups (P>0.05). The difference of postoperative score of symptoms, operation time, intraocular pressure, reoperation rate because of retinal detachment and vitreous hemorrhage were all not statistically significant between the two groups(P=0.070, 0.367, 0.503, 0.667). Conclusion 27G and 25G are equally safe and effective in the treatment of diabetic retinopathy. Key words: Retinopathy, diabetic, proliferative; Vitrectomy, 25G, 27G; Visual acuity
目的比较27G玻璃体切除术与25G玻璃体切除术治疗增殖性糖尿病视网膜病变(PDR)的疗效。方法回顾性分析我院2017年1月至2017年12月行玻璃体切除术的185例PDR患者185只眼的资料。所有病例分为两组。27G玻璃体切除术组64眼,25G玻璃体切除术组121眼。结果两组术前基线资料比较,差异无统计学意义(P>0.05)。两组患者术后症状评分、手术时间、眼压、视网膜脱离、玻璃体出血再手术率差异均无统计学意义(P=0.070、0.367、0.503、0.667)。结论27G与25G治疗糖尿病视网膜病变安全有效。关键词:视网膜病变,糖尿病,增生性;玻璃体切除术,25G, 27G;视敏度
{"title":"Comparison of efficacy between 27G and 25G vitrectomy for proliferative diabetic retinopathy","authors":"Yan Gao, Li-li Yuan, Dong-chang Zhang, Dongping Li","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.10.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.10.005","url":null,"abstract":"Objective \u0000To compare the efficacy between 27G and 25G vitrectomy for the treatment of proliferative diabetic retinopathy (PDR). \u0000 \u0000 \u0000Methods \u0000The data of 185 eyes of 185 cases of PDR who received vitrectomy in this hospital from Jan. 2017 to Dec. 2017 were analyzed retrospectively. All cases were divided into two groups. There were 64 eyes in the 27G vitrectomy group and 121 eyes in the 25G vitrectomy group. \u0000 \u0000 \u0000Results \u0000There was no significant difference in the preoperative baseline data between the two groups (P>0.05). The difference of postoperative score of symptoms, operation time, intraocular pressure, reoperation rate because of retinal detachment and vitreous hemorrhage were all not statistically significant between the two groups(P=0.070, 0.367, 0.503, 0.667). \u0000 \u0000 \u0000Conclusion \u000027G and 25G are equally safe and effective in the treatment of diabetic retinopathy. \u0000 \u0000 \u0000Key words: \u0000Retinopathy, diabetic, proliferative; Vitrectomy, 25G, 27G; Visual acuity","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"22 1","pages":"740-743"},"PeriodicalIF":0.0,"publicationDate":"2019-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87306904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of IOL-capsular complex dislocation 人工晶状体-囊复合脱位的治疗
Pub Date : 2019-10-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.10.003
Zongsheng Zeng, Guangbin Zhang
Objective To evaluate the efficacy of IOL exchange with iris-claw IOL(Artisan) for intraocular IOL-capsule complex dislocation. Methods Retrospective case series.The data of 8 eyes of 8 cases of IOL-capsule dislocation accepted IOL exchange with Artisan IOL from Apr. 2015 to Jan. 2018 in this hospital were analyzed. Results The followed-up time was 6-18 months.Postoperative UCVA (LogMAR) was significantly ameliorated from 1.09±0.56 to 0.34±0.11(t=3.989, P=0.005). Postoperative BCVA(LogMAR) was also significantly ameliorated from 0.29±0.12 to 0.18±0.10(t=3.913, P=0.007). There was no significant difference in intraocular pressure(t=1.706, P=0.132)between before and after surgery[(12.60±1.87)mmHg v. s.(10.31±4.67)mmHg(1 mmHg=0.133 kPa)]. Mean postoperative endothelial cell density(ECD) was (2 161.25±358.95)/mm2, preoperative ECD was (2 411.13±404.44)/mm2, and the difference was statistically significant(t=4.686, P=0.002). There was no significant difference in central macular thickness (CMT)(t=-1.974, P=0.089) between before and after surgery [(197.63±32.04)μm v. s.(205.13±30.44)μm]. Conclusion Artisan IOL for the treatment of IOL-capsule complex dislocation is an effective and safe surgical procedure. Key words: Dislocation, complex IOL; IOL, iris-claw, Artisan; Exchange
目的评价人工晶状体置换虹膜-爪式人工晶状体(Artisan)治疗人工晶状体-囊复合脱位的疗效。方法回顾性病例系列。对该院2015年4月至2018年1月8眼接受人工晶状体置换的8例人工晶状体囊脱位患者的资料进行分析。结果随访6 ~ 18个月。术后UCVA (LogMAR)由1.09±0.56显著改善至0.34±0.11(t=3.989, P=0.005)。术后BCVA(LogMAR)也由0.29±0.12显著改善至0.18±0.10(t=3.913, P=0.007)。手术前后眼压差异无统计学意义(t=1.706, P=0.132)[(12.60±1.87)mmHg vs .(10.31±4.67)mmHg(1 mmHg=0.133 kPa)]。术后平均内皮细胞密度(ECD)为(2 161.25±358.95)/mm2,术前平均ECD为(2 411.13±404.44)/mm2,差异有统计学意义(t=4.686, P=0.002)。手术前后黄斑中央厚度(CMT)差异无统计学意义(t=-1.974, P=0.089)[(197.63±32.04)μm vs .(205.13±30.44)μm]。结论人工晶状体植入术治疗人工晶状体囊复杂性脱位是一种安全有效的手术方法。关键词:脱位;复杂人工晶状体;IOL,虹膜爪,Artisan;交换
{"title":"Treatment of IOL-capsular complex dislocation","authors":"Zongsheng Zeng, Guangbin Zhang","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.10.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.10.003","url":null,"abstract":"Objective \u0000To evaluate the efficacy of IOL exchange with iris-claw IOL(Artisan) for intraocular IOL-capsule complex dislocation. \u0000 \u0000 \u0000Methods \u0000Retrospective case series.The data of 8 eyes of 8 cases of IOL-capsule dislocation accepted IOL exchange with Artisan IOL from Apr. 2015 to Jan. 2018 in this hospital were analyzed. \u0000 \u0000 \u0000Results \u0000The followed-up time was 6-18 months.Postoperative UCVA (LogMAR) was significantly ameliorated from 1.09±0.56 to 0.34±0.11(t=3.989, P=0.005). Postoperative BCVA(LogMAR) was also significantly ameliorated from 0.29±0.12 to 0.18±0.10(t=3.913, P=0.007). There was no significant difference in intraocular pressure(t=1.706, P=0.132)between before and after surgery[(12.60±1.87)mmHg v. s.(10.31±4.67)mmHg(1 mmHg=0.133 kPa)]. Mean postoperative endothelial cell density(ECD) was (2 161.25±358.95)/mm2, preoperative ECD was (2 411.13±404.44)/mm2, and the difference was statistically significant(t=4.686, P=0.002). There was no significant difference in central macular thickness (CMT)(t=-1.974, P=0.089) between before and after surgery [(197.63±32.04)μm v. s.(205.13±30.44)μm]. \u0000 \u0000 \u0000Conclusion \u0000Artisan IOL for the treatment of IOL-capsule complex dislocation is an effective and safe surgical procedure. \u0000 \u0000 \u0000Key words: \u0000Dislocation, complex IOL; IOL, iris-claw, Artisan; Exchange","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"1 1","pages":"731-735"},"PeriodicalIF":0.0,"publicationDate":"2019-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90818079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluid-air exchange with single syringe for the treatment of persistent macular hole after vitrectomy 单注射器液气交换治疗玻璃体切除术后持续性黄斑裂孔
Pub Date : 2019-10-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.10.014
Hu Aa, Chen Fang, Jie Zhenggao
Objective To evaluate the efficacy of single syringe fluid-air exchange (SSFAE) for the treatment of persistent idiopathic macular hole(IMH) after vitrectomy. Methods The data of 11 eyes of 10 cases with persistent IMH after vitrectomy from Jan.2015 to Aug.2018 at Subei People’s Hospital Affiliated to Yangzhou University were retrospectively analyzed. All cases received SSFAE in outpatient department. The closure rate of macular hole and the changes of visual acuity after SSFAE were evaluated. Results The rate of macular hole closed after the first SSFAE was 63.63% (7/11), 72.72% (8/11) after the second SSFAE and 81.81% (9/11) after the third SSFAE. Conclusion SSFAE is a simple, safe and efficient method for the treatment of persistent IMH after vitrectomy. Key words: Hole, macular; Vitrectomy; Exchange, fluid-air, single syringe
目的评价单针液气交换术(SSFAE)治疗玻璃体切除术后持续性特发性黄斑孔(IMH)的疗效。方法回顾性分析2015年1月至2018年8月在扬州大学附属苏北人民医院玻璃体切除术后10例持续性IMH患者11眼的资料。所有病例均在门诊接受SSFAE治疗。观察SSFAE术后黄斑孔闭合率及视力变化。结果第一次术后黄斑孔闭合率为63.63%(7/11),第二次术后72.72%(8/11),第三次术后81.81%(9/11)。结论SSFAE是治疗玻璃体切除术后持续性IMH的一种简单、安全、有效的方法。关键词:孔;黄斑;玻璃体切除术;换血,液体-空气,单注射器
{"title":"Fluid-air exchange with single syringe for the treatment of persistent macular hole after vitrectomy","authors":"Hu Aa, Chen Fang, Jie Zhenggao","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.10.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.10.014","url":null,"abstract":"Objective \u0000To evaluate the efficacy of single syringe fluid-air exchange (SSFAE) for the treatment of persistent idiopathic macular hole(IMH) after vitrectomy. \u0000 \u0000 \u0000Methods \u0000The data of 11 eyes of 10 cases with persistent IMH after vitrectomy from Jan.2015 to Aug.2018 at Subei People’s Hospital Affiliated to Yangzhou University were retrospectively analyzed. All cases received SSFAE in outpatient department. The closure rate of macular hole and the changes of visual acuity after SSFAE were evaluated. \u0000 \u0000 \u0000Results \u0000The rate of macular hole closed after the first SSFAE was 63.63% (7/11), 72.72% (8/11) after the second SSFAE and 81.81% (9/11) after the third SSFAE. \u0000 \u0000 \u0000Conclusion \u0000SSFAE is a simple, safe and efficient method for the treatment of persistent IMH after vitrectomy. \u0000 \u0000 \u0000Key words: \u0000Hole, macular; Vitrectomy; Exchange, fluid-air, single syringe","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"295 1","pages":"784-788"},"PeriodicalIF":0.0,"publicationDate":"2019-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75181579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of vertical chop combined with horizontal chop in hard nuclear cataract surgery 纵切联合横切在硬核白内障手术中的应用
Pub Date : 2019-10-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2019.10.008
Liu Junning, Lin Chenjuan, H. Zhen, Li Yuan
Objective To evaluate the efficacy of vertical chop combined with horizontal chop in hard nuclear cataract surgery. Methods A retrospective study. Total of 86 eyes of 86 patients with senile cataract were randomly divided into two groups, and all nuclear classification ranged from IV to V. Group A, 43 patients, received vertical chop combined with horizontal chop. Group B, 43 patients, received phacoemulsification with high vacuum splitting. The efficacy were compared between the two groups. Results The ultrasonic time (UST) was (67.77±14.68) s of group A and (103.09±44.89) s of group. The cumulative dissipated energy (CDE) was 35.33±12.75 of group A and 41.25±14.35 in group B. The difference in UST and CDE were significant statistically between the two groups (P 0.3 occupied 86.05 % in group A and 67.44 % in group B (P=0.04). The corneal edema at 1 day postoperatively in group A was lower than that in group B, the difference was statistically significant between the two groups (P=0.03). The difference in degree of corneal edema at 7 days after surgery was not statistically significant between the two groups. The corneal endothelial cells (CECs) in 1 month postoperatively was (2 371.30±179.02)/mm2 in group A and (2 157.80±156.46)/mm2 in group B(P<0.01). The loss rate of CECs was (8.73±3.74)% in group A and (15.41±3.54)% in group B(P<0.01). Conclusion Application of vertical nuclear chop combined with horizontal nuclear chop in hard nuclear cataracts surgery is effective. Key words: Cataracts, hard nuclear; Chop, vertical; Chop, horizontal
目的评价垂直切割联合水平切割在硬核性白内障手术中的疗效。方法回顾性研究。将86例老年性白内障患者86只眼随机分为两组,核分型均为IV ~ v。A组43例,行纵切联合横切。B组43例采用高真空劈裂超声乳化术。比较两组患者的疗效。结果A组超声时间(67.77±14.68)s, A组超声时间(103.09±44.89)s。A组累积耗散能(CDE)为35.33±12.75,B组为41.25±14.35,两组间差异有统计学意义(P=0.04, A组P= 0.3占86.05%,B组P=0.04占67.44%)。A组术后1 d角膜水肿明显低于B组,两组比较差异有统计学意义(P=0.03)。两组术后7天角膜水肿程度差异无统计学意义。术后1个月,A组角膜内皮细胞(CECs)为(2 371.30±179.02)个/mm2, B组为(2 157.80±156.46)个/mm2 (P<0.01)。A组CECs损失率为(8.73±3.74)%,B组为(15.41±3.54)% (P<0.01)。结论在硬核白内障手术中应用垂直核切割联合水平核切割是有效的。关键词:白内障;硬核;切,垂直;排骨、水平
{"title":"Application of vertical chop combined with horizontal chop in hard nuclear cataract surgery","authors":"Liu Junning, Lin Chenjuan, H. Zhen, Li Yuan","doi":"10.3760/CMA.J.ISSN.2095-1477.2019.10.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2019.10.008","url":null,"abstract":"Objective \u0000To evaluate the efficacy of vertical chop combined with horizontal chop in hard nuclear cataract surgery. \u0000 \u0000 \u0000Methods \u0000A retrospective study. Total of 86 eyes of 86 patients with senile cataract were randomly divided into two groups, and all nuclear classification ranged from IV to V. Group A, 43 patients, received vertical chop combined with horizontal chop. Group B, 43 patients, received phacoemulsification with high vacuum splitting. The efficacy were compared between the two groups. \u0000 \u0000 \u0000Results \u0000The ultrasonic time (UST) was (67.77±14.68) s of group A and (103.09±44.89) s of group. The cumulative dissipated energy (CDE) was 35.33±12.75 of group A and 41.25±14.35 in group B. The difference in UST and CDE were significant statistically between the two groups (P 0.3 occupied 86.05 % in group A and 67.44 % in group B (P=0.04). The corneal edema at 1 day postoperatively in group A was lower than that in group B, the difference was statistically significant between the two groups (P=0.03). The difference in degree of corneal edema at 7 days after surgery was not statistically significant between the two groups. The corneal endothelial cells (CECs) in 1 month postoperatively was (2 371.30±179.02)/mm2 in group A and (2 157.80±156.46)/mm2 in group B(P<0.01). The loss rate of CECs was (8.73±3.74)% in group A and (15.41±3.54)% in group B(P<0.01). \u0000 \u0000 \u0000Conclusion \u0000Application of vertical nuclear chop combined with horizontal nuclear chop in hard nuclear cataracts surgery is effective. \u0000 \u0000 \u0000Key words: \u0000Cataracts, hard nuclear; Chop, vertical; Chop, horizontal","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":"23 1","pages":"755-759"},"PeriodicalIF":0.0,"publicationDate":"2019-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85719579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华眼外伤职业眼病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1